Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Research and Markets has announced the addition of the "Biotechnology/Pharmaceutical Services Outsourcing Market Analysis, By Service And Segment Forecasts, 2014 - 2025" report to their offering.
read more
The U.S. Food and Drug Administration's (FDA) recent approval of Zarxio (filgrastim-sndz) -- the first biosimilar product approved in the United States -- points toward growth in the contract manufacturing organization (CMO) industry, according to ...
read more
Thursday, November 05, 2015
The U.S. health care system saved a record $254 billion in 2014 from generic drugs, which amounts to $1.68 trillion over the most recent decade (2005-2014), according to the seventh annual Generic Drug Savings in the United States report compiled by ...
read more
The global pharmaceutical analytical testing outsourcing market is expected to reach $9.6 billion by 2025 according to a recent report by Research and Markets.
read more
The market for drug discovery tasks that outsourced by pharmaceutical companies to contract research organizations (CROs) and others is estimated to reach $21 billion in 2016, according to Kalorama Information.
read more
Wednesday, September 28, 2016
The global contract manufacturing organization (CMO) market is transforming to leverage changes in the pharmaceutical industry. Pharmaceutical companies continue to gain financially and overcome marketplace challenges, source innovative ideas, ...
read more
The report, Global Active Pharmaceutical Ingredients Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. ...
read more
Industry Standard Research (ISR) has announced the availability of the "Contract Manufacturer Quality Benchmarking (2015)" report, providing a comprehensive assessment of CMO service quality.
read more
The global pharmaceutical contract manufacturing/contract research market is anticipated to reach USD 238.3 billion by 2025, according to a new report by Grand View Research.
read more
Thursday, October 05, 2017
Many pharmaceutical manufacturers are switching to continuous production from batch methods.
read more
Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing & Contract Research Market, 2014 - 2025" report to their offering.
read more
Global post-marketing pharmacovigilance and medical information market is expected to reach USD 5.3 Billion by 2022, according to a new report by Grand View Research, Inc.
read more
Wednesday, March 30, 2016
Greater acceptance of biosimilar medicines in a growing number of therapy areas and an active pipeline of 56 new products in clinical development are expected to deliver total savings of as much as $110 billion to health systems across Europe and the...
read more
More than 1 in 5 sexually active teen girls have used the morning-after pill — a dramatic increase that likely reflects that it's easier now for teens to buy the emergency contraceptive.
read more
Tuesday, November 10, 2020
Repositive has expanded its global network of CRO partners with the addition of Pharmatest, a CRO providing clinically predictive preclinical efficacy services for oncology and skeletal diseases.
read more